- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/08 - Tripeptides
Détention brevets de la classe C07K 5/08
Brevets de cette classe: 666
Historique des publications depuis 10 ans
|
40
|
53
|
49
|
50
|
40
|
37
|
33
|
20
|
27
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Purdue Research Foundation | 3913 |
28 |
| Bristol-myers Squibb Company | 4729 |
15 |
| ISP Investments Inc. | 442 |
15 |
| Ajinomoto Co., Inc. | 2279 |
9 |
| Hoffmann-La Roche Inc. | 3783 |
8 |
| The Regents of the University of California | 20720 |
8 |
| Onyx Therapeutics, Inc. | 66 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
7 |
| Genentech, Inc. | 4099 |
6 |
| DSM IP Assets B.V. | 5376 |
6 |
| Novozymes A/S | 3382 |
6 |
| Rhythm Pharmaceuticals, Inc. | 94 |
6 |
| Boehringer Ingelheim International GmbH | 4493 |
5 |
| Agency for Science, Technology and Research | 3729 |
5 |
| InterMune, Inc. | 47 |
5 |
| Supadelixir Inc. | 25 |
5 |
| Merck Sharp & Dohme LLC | 3735 |
5 |
| California Institute of Technology | 4043 |
4 |
| University of Florida Research Foundation, Inc. | 4173 |
4 |
| Enanta Pharmaceuticals, Inc. | 429 |
4 |
| Autres propriétaires | 507 |